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Abstract
Background: Nfkb1-deficient murine macrophages express higher levels of IFN-b and IL-12 p40 following LPS stimulation
than control macrophages, but the molecular basis for this phenomenon has not been completely defined. Nfkb1 encodes
several gene products including the NF-kB subunit p50 and its precursor p105. p50 is derived from the N-terminal of 105,
and p50 homodimers can exhibit suppressive activity when overexpressed. The C-terminal region of p105 is necessary for
LPS-induced ERK activation and it has been suggested that ERK activity inhibits both IFN-b and IL-12 p40 following LPS
stimulation. However, the contributions of p50 and the C-terminal domain of p105 in regulating endogenous IFN-b(Ifnb)
and IL-12 p40 (Il12b) gene expression in macrophages following LPS stimulation have not been directly compared.
Methodology/Principal Findings: We have used recombinant retroviruses to express p105, p50, and the C-terminal domain
of p105 (p105DN) in Nfkb1-deficient murine bone marrow-derived macrophages at near endogenous levels. We found that
both p50 and p105DN inhibited expression of Ifnb, and that inhibition of Ifnb by p105DN depended on ERK activation,
because a mutant of p105DN (p105DNS930A) that lacks a key serine necessary to support ERK activation failed to inhibit. In
contrast, only p105DN but not p50 inhibited Il12b expression. Surprisingly, p105DNS930A retained inhibitory activity for
Il12b, indicating that ERK activation was not necessary for inhibition. The differential effects of p105DNS930A on Ifnb and
Il12b expression inversely correlated with the function of one of its binding partners, c-Rel. This raised the possibility that
p105DNS930A influences gene expression by interfering with the function of c-Rel.
Conclusions: These results demonstrate that Nfkb1 exhibits multiple gene-specific inhibitory functions following TLR
stimulation of murine macrophages.
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Introduction
The transcription factor NF-kB plays a central role in regulating
innate immune gene expression [1]. While NF-kB is generally
considered a pro-inflammatory factor, LPS induces significantly
higher levels of the genes for IFN-b (Ifnb) and IL-12 p40 (Il12b)i n
macrophages derived from mice with targeted deletions in Nfkb1,
the gene coding for the p50 subunit of NF-kB, than in WT
macrophages [2–8]. Thus Nfkb1 is an inhibitor of key immuno-
regulatory genes, and this is manifest in the observation that
Nfkb1
2/2 mice are highly susceptible to microflora-induced colitis
[9]. However, the molecular basis for selective inhibition of Ifnb
and Il12b by Nfkb1 has not been completely defined.
Nfkb1 has multiple gene products. Its full-length gene product
p105 is a bipartite molecule consisting of an N-terminal Rel
homology domain and a C-terminal ankyrin repeat domain [10–
15]. Constitutive processing of p105 by the proteosome removes
the C-terminal domain of p105 to generate p50 monomers, which
then homodimerize or heterodimerize with other NF-kB family
members [16]. In contrast to the constitutive processing of p105 to
p50, LPS induces IkB kinase (IKK)-dependent complete degra-
dation of p105 [17–19]. IKK mediates the phosphorylation of
p105 at serine 930, which is located within a C-terminal amino
acid sequence partially homologous to the N-terminal IKK-
dependent phospho-acceptor sites in IkB-a, and mutations of S930
inhibit IKK-mediated inducible degradation of p105 [18,20,21].
It has previously been suggested that p50 homodimers are
inhibitory based on their ability to prevent binding of more active
NF-kB dimers to kB sites necessary for inflammatory gene
expression [22,23]. Nevertheless, this does not explain why the
absence of Nfkb1 selectively affects expression of Ifnb and Il12b.
Recently, it has been proposed that p50 binds to a G-rich
sequence within the Ifnb interferon stimulated response element
(ISRE) and interferes with recruitment of IRF-3. This potentially
explains the selective increase in IFN-dependent gene expression
observed in Nfkb1
2/2 macrophages [3], although it is not yet clear
whether expression of p50 alone is sufficient to inhibit Ifnb
expression in Nfkb1
2/2 macrophages. Further, while expression of
Il12b does not appear to be dependent on IRF-3 [24], it does
contain an ISRE in its proximal promoter region [25,26], but it
has not yet been determined whether p50 is sufficient to inhibit
LPS-induced Il12b.
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mediated inhibition of Ifnb, we have proposed that the ability of
the C-terminal region of p105 to facilitate ERK activation is
responsible for inhibition of LPS-induced Ifnb expression [8]. ERK
inhibitors enhance LPS-induced expression of Ifnb and Il12b in
macrophages [27–29]. The C-terminal portion of p105 binds to
and stabilizes Tpl-2, a MAP3K that is essential for ERK activation
[17,30], and as a result, LPS-induced ERK activation is blocked in
Nfkb1
2/2 bone marrow-derived macrophages (BMDM) [19]. It
has been suggested that the basis of ERK-mediated inhibition is its
ability to enhance induction of c-Fos, which inhibits both Ifnb and
Il12b expression [27–29]. We have demonstrated that expression
of a C-terminal fragment of p105 that does not contain the Rel
homology domain (p105DN) rescues LPS-induced ERK activation
and inhibits LPS-induced Ifnb expression [8]. However, whether
the ability of p105DN to inhibit Ifnb expression depends upon
ERK activation and whether p105DN is able to inhibit LPS-
induced Il12b expression has not been determined.
To further delineate the molecular basis for Nfkb1-mediated
inhibition, we have directly compared the ability of p105, p50, and
p105DN to inhibit LPS-induced expression of Ifnb and Il12b in
Nfkb1
2/2 murine bone marrow-derived macrophages. In addition,
we have used a mutant of p105DN (p105DNS930A) that is unable
to support ERK activation, to determine whether the inhibitory
function of p105DN depends on its ability to activate ERK.
Results
BMDM were infected with recombinant retroviruses that
expressed either HA tagged full-length p105, p50 (amino acids
1–433), a C-terminal fragment of p105 which lacks the N-terminal
Rel Homology Domain (p105DN, amino acids 434–971), or a
mutant of p105DN in which S930, one of the serines in the C-
terminal phosphorylation site necessary for IKK-dependent
degradation and ERK activation, was mutated to alanine
(p105DNS930A) [17,20] (Fig. 1). Western blotting demonstrated
expression of HA tagged proteins of appropriate sizes (Fig. 2A),
and as expected we observed both p50 and p105 in macrophages
infected with the vector expressing p105. Western blotting with an
N-terminal p105 antibody indicated that levels of p50 and p105 in
virally infected Nfkb1
2/2 cells were similar to endogenous levels
observed in control cells (Fig. 2A). We observed lower protein
levels of p105DN and p105DNS930A than p105, and it is likely
that this is secondary to more rapid turnover, as we observed
similar mRNA levels in BMDM expressing p105, p105DN, or
p105DNS930A using a C-terminal Nfkb1 Taqman RT-PCR probe
(Fig. 2B, right). An N-terminal Nfkb1 probe revealed similar RNA
levels in cells expressing p105 and p50 (Fig. 2B, left).
As expected, LPS induced significantly higher expression of Ifnb
mRNA in Nfkb1
2/2 BMDM infected with vector alone than in
control BMDM infected with the vector alone (Fig 3A). The
presence of p105, p50, and p105DNi nNfkb1
2/2 BMDM all
significantly inhibited expression of Ifnb mRNA at the point of
peak induction 2 hours after LPS treatment, and these differences
were mimicked by differences in IFN-b accumulation in the cell
supernatants (Fig. 3B). These results indicate that both p50 and the
C-terminal fragment of p105 independently inhibit expression of
Ifnb.
It has previously been demonstrated that phosphorylation of
S930 in p105 is essential for LPS-induced ERK activation [20,21].
It has been proposed that ERK activation is associated with
suppression of LPS-induced Ifnb and Il12b expression because it is
necessary for induction of c-Fos, an inhibitor of both Ifnb and Il12b
[29]. However, it has not been demonstrated whether phosphor-
ylation at S930 is necessary for inhibition of Ifnb expression by
p105DN. In contrast to p105DN, p105DNS930A did not inhibit
LPS-induced Ifnb mRNA expression (Fig. 3A) or accumulation of
IFN-b in cell supernatants (Fig. 3B), and in fact Ifnb mRNA was
expressed at significantly higher levels in Nfkb1
2/2 BMDM
expressing p105DNS930A than in Nfkb1
2/2 BMDM infected
with vector alone (Fig. 3A). Consistent with a role for
phosphorylation of serine 930 in LPS-induced ERK activation
and stabilization of c-Fos, expression of p105DN but not
p105DNS930A rescued the defect in ERK activation and c-Fos
induction observed in Nfkb1
2/2 BMDM (Fig. 4). As expected,
LPS-induced degradation of p105DNS930A was impaired (Fig. 4).
These results demonstrate that phosphorylation of S930 plays an
essential role in mediating the ability of the C-terminal region of
p105 to inhibit LPS-induced Ifnb expression, and that this is
strongly associated with activation of ERK and induction of c-Fos.
Further, these results suggest that in the absence of IKK-mediated
phosphorylation at S930, p105DN demonstrates an activity that
enhances LPS-induced expression of Ifnb mRNA.
Consistent with previous results [4,6,7], LPS also induced
higher levels of Il12b in Nfkb1
2/2 cells than in control cells
following infection with vector alone (Fig. 5). To determine
Figure 1. Domain structure of p105. Diagram showing p105, p50, and constructs p105DN and p105DNS930A.
doi:10.1371/journal.pone.0032811.g001
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PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e32811Figure 2. Retrovirally-mediated expression of Nfkb1 constructs. A) Immunoblotting of Il10
2/2Rag2
2/2 (Control) or Nfkb1
2/2Il10
2/2Rag2
2/2
(Nfkb1
2/2) BMDM infected with empty vector (Vector) or viruses expressing the indicated proteins. Total cell extracts from unstimulated cells were
probed with the indicated antibodies (left) by western blotting. Arrows indicate size of Nfkb1-derived gene product (right). NS refers to a non-specific
band. B) Relative expression of Nfkb1 N- and C-terminal derived mRNA as determined by RT-PCR. N=3 mice per group.
doi:10.1371/journal.pone.0032811.g002
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employed for inhibition of Ifnb, we evaluated expression of Il12b in
RNA samples from the virus-infected macrophages described
above. As expected, p105 significantly inhibited expression of Il12b
at both 2 (data not shown) and 4 hours after treatment with LPS
(Fig. 5A). However, contrary to results with Ifnb, p50 did not
significantly influence Il12b expression, suggesting that p50 is not
an important inhibitor of Il12b following LPS treatment (Fig. 5A).
In contrast, p105DN significantly inhibited expression of Il12b.
However, we were surprised to find that inhibition did not depend
on ERK activation or the induction of c-Fos, as p105DNS930A
also significantly inhibited Il12b expression (Fig. 5A), demonstrat-
ing that inhibition of Il12b expression by p105DN was proceeding
in an ERK and c-Fos independent fashion. Indeed, inhibition by
p105DNS930A consistently appeared somewhat more robust than
inhibition by p105DN, although this did not reach statistical
Figure 3. Both p50 and p105DN inhibit LPS-induced Ifnb in Nfkb1
2/2 macrophages. A) Relative expression of Ifnb as determined by RT-PCR
in Il10
2/2Rag2
2/2 (control) or Nfkb1
2/2Il10
2/2Rag2
2/2 (Nfkb1
2/2) BMDM infected with empty vector (Vector) or viruses expressing indicated
proteins 2 hours after stimulation with LPS. N=6–9 individual mice per group. B) Concentration of IFN-b in the supernatant of BMDM as determined
by ELISA 12 hours after stimulation with LPS. N=6 mice per group.
doi:10.1371/journal.pone.0032811.g003
Figure 4. p105 serine 930 is essential for ERK activation and induction of c-Fos. Immunoblotting with indicated antibodies (right) of
extracts derived from Il10
2/2Rag2
2/2 (control) or Nfkb1
2/2Il10
2/2Rag2
2/2 (Nfkb1
2/2) BMDM infected with empty vector (Vector) or viruses
expressing indicated proteins, prior to stimulation, or at 15 and 120 minutes after LPS stimulation.
doi:10.1371/journal.pone.0032811.g004
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closely correlated with differences observed in the accumulation of
IL-12 p40 in cell supernatants (Fig. 5B).
The experiments described above employing p105DNS930A
demonstrate that in the absence of the ability to activate ERK, the
C-terminal region of p105 retains the ability to inhibit Il12b but
enhances expression of Ifnb mRNA. In addition to facilitating LPS-
induced ERK activation, the C-terminal region of p105 contains
ankyrin repeats similar to those found in the classical IkBs [14,15]. It
has been shown that this region mediates association between p105
and both p65 and c-Rel [12,15,31,32]. c-Rel is necessary for LPS-
induced Il12b expression in macrophages [33,34] and therefore
inhibition of c-Rel function by the C-terminal region of p105 could
explain the ability of p105DNS930A to inhibit Il12b. Conversely,
inhibition of c-Rel function could explain the ability of
p105DNS930A to augment Ifnb induction if c-Rel is an inhibitor of
Ifnb. In fact, we observed that Rel
2/2 BMDM expressed significantly
higher levels of Ifnb mRNA 2 hours after LPS stimulation than
control macrophages, while, as expected, they expressed markedly
lower levels of Il12b mRNA (Figs. 6A and 6B). These results were
c l o s e l ym i m i c k e db yt h ea c c u m u l a t i o no fI F N - b and IL-12 p40 in cell
supernatants (Figs. 6C and 6D). These results suggest that inhibition
of c-Rel function by the C-terminal region of p105 could have
differential effects on the expression of Il12b and Ifnb.
Discussion
We have shown that Nfkb1 inhibits LPS-induced gene
expression by multiple gene-specific mechanisms. p50 inhibits Ifnb
but not Il12b. In contrast, the C-terminal region of p105 plays a
role in inhibition of both Ifnb and Il12b, but only inhibition of Ifnb
requires the ability of this C-terminal region to activate ERK.
It was previously proposed that homodimers of p50 inhibit
access of more active Rel dimers to kB sites present with the
promoter regions of NF-kB target genes [22]. However, a recent
study demonstrated that promoters of genes expressed at higher
levels in Nfkb1-deficient cells are enriched for ISRE-like sequences
that contain short G-rich stretches [3]. It was proposed that these
G-rich stretches serve as cryptic binding sites for p50 homodimers,
which prevent recruitment of basal IRF-3. The promoter for Ifnb
contains such an ISRE [3], but it has not been previously
determined whether p50 alone is capable of inhibiting LPS-
induced expression of endogenous Ifnb in Nfkb1
2/2 macrophages.
Here we show that expression of p50 in Nfkb1
2/2 BMDM can
inhibit expression of Ifnb, which is consistent with a model in
which binding of p50 to the Ifnb ISRE inhibits Ifnb expression.
In contrast to its ability to inhibit Ifnb expression, p50 was
unable to inhibit expression of Il12b. The fact that p50 was
expressed above endogenous levels but was still unable to inhibit
Il12b indicates that this failure was not an artifact of low expression
levels. The Il12b promoter has previously been demonstrated to
contain an atypical NF-kB binding site that consists of a stretch of
Gs, termed an NF-kB half site [35], as well as an ISRE [25,26].
However the presence of these sites is clearly not sufficient to
support inhibition of Il12b by p50, indicating that p50 has highly
selective inhibitory function. Whether this selectivity is solely based
on the presence of G-rich ISRE sequences and inhibition of IRF-3
recruitment remains to be determined.
Figure 5. p105DN but not p50 inhibit LPS-induced Il12b expression in Nfkb1
2/2 macrophages. A) Relative expression of IL-12 p40 (Il12b)
as determined by RT-PCR in Il10
2/2Rag2
2/2 (control) or Nfkb1
2/2Il10
2/2Rag2
2/2 (Nfkb1
2/2) BMDM infected with empty vector (Vector) or viruses
expressing the indicated proteins 4 hours after stimulation with LPS (N=6–9 individual mice per group). B) Levels of IL-12 p40 present in the
supernatant of groups described in A, 2 hours after stimulation with LPS (N=3 individual mice per group).
doi:10.1371/journal.pone.0032811.g005
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induced expression of both Ifnb and Il12b. Previous studies have
shown that ERK inhibitors increase LPS-induced expression of
both of these genes [27–29], leading us, and others, to hypothesize
that p105 inhibits by facilitating activation of ERK [29,36]. It has
been proposed that ERK-dependent inhibition is mediated by
increased mRNA expression [29] and/or protein stabilization of c-
Fos [27], an inhibitor of both Ifnb and Il12b [27–29]. The results
reported here strongly suggest that the ability of p105DN to rescue
ERK activation and induce c-Fos is necessary to inhibit Ifnb, but in
contrast, is dispensable for inhibition of Il12b.
The C-terminal fragment of p105 contains multiple ankyrin
repeats similar to those found in other IkBs [11,12,14,15], and it
has been suggested that p105 may preferentially interact with c-
Rel [12,15,31,32]. c-Rel is essential for LPS-induced expression of
Il12b [33] and thus inhibition of c-Rel function by p105DN could
explain inhibition of Il12b. This is supported by the observation
that p105DNS930A, which is resistant to IKK-mediated degra-
dation, may be a better inhibitor of Il12b expression than p105DN
itself. Interestingly, we have found that in contrast to its effects on
Il12b expression, c-Rel inhibits LPS-induced expression of Ifnb.
Thus, more robust inhibition of c-Rel function by p105DNS930A
than by p105DN could explain why p105DNS930A actually
augments expression of Ifnb. While one potential mechanism for
inhibition of c-Rel function by p105DNS930A is inhibition of
nuclear localization following LPS stimulation, we have not
observed increased c-Rel nuclear translocation in Nfkb1-deficient
BMDM nor have we observed inhibition of c-Rel nuclear
translocation by p105DNS930A (data not shown). Therefore the
functional consequences of c-Rel interaction with p105 remain to
be fully elucidated.
The studies presented here provide new insight into the
mechanisms of gene inhibition by Nfkb1. They demonstrate that
Nfkb1 has multiple inhibitory mechanisms that function in gene-
specific manners. Further they illustrate that rather than an on/off
switch for inflammation, NF-kB is a complex modulator of the
innate response that differentially influences key immunoregula-
tory cytokines. Understanding the molecular details of gene-
Figure 6. c-Rel inhibits LPS-induced expression of Ifnb. A) Relative expression of Ifnb and Il12b as determined by RT-PCR in Il10
2/2Rag2
2/2
(open bars) and Rel
2/2Il10
2/2Rag2
2/2 (filled bars) BMDM at indicated time points after stimulation with LPS. N=3 mice per group. Repeated 3 times
with similar results. B) Levels of IFN-b and IL-12 p40 in supernatants of Il10
2/2Rag2
2/2 (Control) and Rel
2/2Il10
2/2Rag2
2/2 (Rel
2/2) BMDM 4 hours
after stimulation with LPS. N=5 mice per group.
doi:10.1371/journal.pone.0032811.g006
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therapeutic modulation of immune and inflammatory based
diseases.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
animal protocol was approved by the Harvard Medical Area
Standing Committee on Animals (OLAW Assurance number:
A34131-01). All efforts were made to minimize suffering.
Experimental Animals
All mouse strains were maintained on the 129S6/SvEvTac
background. Il10
2/2Rag2
2/2 (control) and Nfkb1
2/2Il10
2/2
Rag2
2/2 (Nfkb1
2/2) mice have been previously described [8].
Rel
2/2Il10
2/2Rag2
2/2 (Rel
2/2) mice were generated by inter-
crossing Rel
2/2Rag2
2/2 [8] and Il10
2/2Rag2
2/2 mice. Macro-
phages were derived from mice maintained on the Il10
2/2
background to eliminate the effects of the strong IL-10 feedback
loop on LPS-induced gene expression, and on the Rag2
2/2
background to prevent the development of spontaneous colitis.
Retrovirally-mediated gene expression
BMDM were grown as previously described [36]. On the
second day of culture cells were infected with the indicated
retroviruses. 72 hours later macrophages were re-plated at 5610
5
cells/well in 0.5 ml of medium in a 24-well plate, or at 0.3–1610
5
cells/well in 100 ml of medium in a 96 well plate. The following
day cells were stimulated with LPS from E. coli 0127:B8 (Sigma, St
Louis, MO) at 1 ng/ml or left unstimulated.
RT-PCR
RNA was isolated in Trizol (Invitrogen, Carlsbad, CA)
following the manufacturer’s instructions. RT-PCR analysis was
performed using probes from Applied Biosystems (Foster City,
CA), as per the manufacturer’s instructions. Expression for each
sample was analyzed in duplicate and normalized to GAPDH
using the DDCt method. Fold-change is reported as relative to the
average of uninduced levels in unstimulated BMDM for each
experiment.
ELISA
IFN-b was analyzed in culture supernatants using an IFN-b-
specific ELISA kit (PBL Biomedical Laboratories) according to the
manufacturer’s instructions. IL-12 p40 was analyzed via ELISA
using C15.6 (Biolegend, San Diego, CA) as the capture antibody
and C17.8 (Thermo Scientific, Rockford, IL) as the secondary
antibody.
Antibodies
Anti-ERK (p44/42 MAP Kinase), anti-phospho ERK (p44/42
MAP Kinase) (Thr202/Tyr204), and anti-c-Fos (9F6) were
purchased from Cell Signaling (Beverly, MA). Anti-N-terminal
p105 (sc-1190) was purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-HA (16B12) was purchased from Covance
(Princeton, NJ).
Statistical Analysis
All data analysis was performed using GraphPad Prism software
(GraphPad Software, inc., San Diego, CA). Data generated by
RT-PCR or ELISA was compared using One-way ANOVA with
the Tukey’s multiple comparison test. Error bars on graphs
represent SEM. * indicates p,0.05, ** indicates p,0.01, and ***
indicates p,0.001.
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